Moreover, the development and progression of type I endometrioid adenocarcinomas depend on the normal function of estrogen and progesterone receptors (ER and PR, respectively); it has been repeatedly shown that silencing of both ER and PR by aberrant DNA methylation is a recurrent feature in EC (summarized by [62]). The gene discussed is PGR; the disease is endometrioid adenocarcinoma.